Biodelivery Sci Intl (BDSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,709 | 5,285 | 21,495 | 33,446 | 48,325 |
| Depreciation Amortization | 1,519 | 6,118 | 4,568 | 2,961 | 1,480 |
| Income taxes - deferred | N/A | -15,972 | -15,972 | -15,972 | -15,972 |
| Accounts receivable | 864 | -5,884 | -7,222 | -2,458 | -2,662 |
| Other Working Capital | -1,051 | -17,982 | -15,800 | -17,322 | -19,762 |
| Other Operating Activity | 2,616 | -4,016 | -7,950 | -17,366 | -20,411 |
| Operating Cash Flow | $-6,761 | $-32,451 | $-20,881 | $-16,711 | $-9,002 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -73 | -11 | -5 | -2 | N/A |
| Net Acquisitions | -1,951 | -5,853 | -3,902 | N/A | N/A |
| Investing Cash Flow | $-2,024 | $-5,864 | $-3,907 | $-2 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 45,000 | 45,000 | 45,000 |
| Common Stock Issued | 130 | 439 | 313 | 0 | 0 |
| Other Financing Activity | -450 | 27,052 | -32,798 | -32,798 | -32,798 |
| Financing Cash Flow | $-320 | $27,491 | $12,515 | $12,202 | $12,202 |
| Beginning Cash Position | 21,195 | 32,019 | 32,019 | 32,019 | 32,019 |
| End Cash Position | 12,090 | 21,195 | 19,746 | 27,508 | 35,219 |
| Net Cash Flow | $-9,105 | $-10,824 | $-12,273 | $-4,511 | $3,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,761 | -32,451 | -20,881 | -16,711 | -9,002 |
| Capital Expenditure | -73 | -11 | -5 | -2 | 0 |
| Free Cash Flow | -6,834 | -32,462 | -20,886 | -16,713 | -9,002 |